Department of Psychiatry Faculty

Michael J. Sernyak, MD Professor of Psychiatry Chief, Psychiatry Service and Mental Health Service Line VA Connecticut Healthcare System West Haven Campus 950 Campbell Avenue West Haven, CT 06516 Tel: 203-932-5711 x2448 Fax: 203-937-3886 Email: michael.sernyak@yale.edu

Education

1983, B.A., Amherst College
1987, M.D., Jefferson Medical College
Residency: Yale University, Psychiatry

Research Interest

My research focuses on treatment issues of the severely mentally ill. My most recent area of focus has been the development of metabolic abnormalities such as diabetes in patients with schizophrenia.

Publications of Note

Sernyak MJ, Desai R, Stolar M, Rosenheck R: Impact of clozapine on completed suicide, American Journal of Psychiatry, 2001: 158(6); 931-937.

Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R: Association of diabetes mellitus with the use of atypical neuroleptics in the treatment of schizophrenia, American Journal of Psychiatry, 2002; 159 (4): 561-566.

Sernyak MJ, Leslie D, Rosenheck R: Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications, American Journal of Psychiatry, 2003; 160 (2): 310-315.

Sernyak MJ, Dausey D, Desai, R, Rosenheck R: Prescriber non-adherence to treatment guidelines despite a self-assessed need for neuroleptic change, Psychiatric Services, 2003; 54: 246-248.

Sernyak MJ, Gulanski B, Leslie DL, Rosenheck R: Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia, Journal of Clinical Psychiatry, 2003; 64 (5):605-608.

Sernyak MJ, Rosenheck R: Clinicians’ reasons for antipsychotic coprescribing, Journal of Clinical Psychiatry, 2004; 65 (12):1597-1600.

Sernyak MJ, Gulanski B, Rosenheck R: Undiagnosed hyperglycemia in patients treated with atypical antipsychotics, Journal of Clinical Psychiatry, 2005; 66(11): 1463-1467.

Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindemayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH: “Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia,” in Journal of Clinical Psychiatry, vol 65 (suppl 7), 2004.

Sernyak MJ, Rosenheck R: Generic fluoxetine and choice of antidepressant medication. Psychiatric Services, in press.

Cohn TA, Sernyak MJ: Metabolic monitoring for patients treated with antipsychotic medications, Canadian Journal of Psychiatry, in press.

Copyright ©2005. Yale University School of Medicine, Psychiatry Department. All rights reserved.
Comments or suggestions to the site editor.

Home URL: http://info.med.yale.edu/ysm